within the fast evolving discipline of oncology analysis, accurate and efficient mutation screening is critical for creating qualified therapies. The KRAS solutions System plays a pivotal job On this landscape by providing complete remedies for KRAS mutation profiling and Investigation. KRAS mutations, present in roughly 95% of RAS-associated oncog